FlowMetric debuts COVID-19 antibody test

2020 12 04 21 33 3125 Sars Co V 2 Covid 19 Mask Pixabay 400

FlowMetric Life Sciences has created a COVID-19 antibody test using its flow cytometry technology that delivers a greater than 99% specificity and greater than 99% sensitivity when testing more than 14 days after COVID-19 symptoms.

The antibody test is able to differentiate an infection due to virus exposure versus a vaccine response, simultaneously identify antibodies of multiple SARS-CoV-2 proteins, and handle double the amount of information over the same testing time period versus the enzyme-linked immunosorbent assay (ELISA) platform, FlowMetric said.

The antibody test is offered at FlowMetric's CLIA-certified, high complexity laboratory, which can process more than 1,000 samples per day with results provided in 24-48 hours, the firm said.

Page 1 of 148
Next Page